These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19816977)

  • 1. Persistent troponin elevation in a patient with cardiac amyloidosis.
    Kraemer BF; Seizer P; Geisler T; Klingel K; Kandolf R; Lindemann S; Gawaz M
    Clin Cardiol; 2009 Nov; 32(11):E39-42. PubMed ID: 19816977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac amyloidosis: a case report and therapeutic implications.
    Kotha AR; Weiss MB
    Heart Dis; 2002; 4(2):86-90. PubMed ID: 11975839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare cause of cardiac decompensation in a patient with left ventricular hypertrophy.
    Mangner N; Gutberlet M; Klingel K; Kandolf R; Schuler G; Linke A
    Clin Res Cardiol; 2012 Nov; 101(11):943-5. PubMed ID: 22645101
    [No Abstract]   [Full Text] [Related]  

  • 4. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.
    Perlini S; Mussinelli R; Salinaro F
    Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senile cardiac amyloidosis: an underappreciated cause of heart failure.
    Shah S; Dungu J; Dubrey SW
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23391947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interpretation of elevated serum troponin levels in end stage renal disease - case 2/2010].
    Artunc F; Haap M; Heyne N; Weyrich P; Wolf S
    Dtsch Med Wochenschr; 2010 Feb; 135(6):240. PubMed ID: 20127607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
    Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
    Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis: new insights into diagnosis and management.
    Eshaghian S; Kaul S; Shah PK
    Rev Cardiovasc Med; 2007; 8(4):189-99. PubMed ID: 18192942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.
    Fernandes F; Antunes MO; Hotta VT; Rochitte CE; Mady C
    Arq Bras Cardiol; 2019 Nov; 113(5):979-987. PubMed ID: 31800724
    [No Abstract]   [Full Text] [Related]  

  • 11. Palpitations in a 64-year-old man.
    Bauml MA; Chung J; Groth JV; Farzaneh-Far A
    Heart; 2014 Jan; 100(2):167-8. PubMed ID: 24281755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.
    Swiger KJ; Friedman EA; Brittain EL; Tomasek KA; Huang S; Su YR; Sawyer DB; Lenihan DJ
    Amyloid; 2016 Dec; 23(4):242-248. PubMed ID: 27809600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy.
    Mabru M; Dacher JN; Bauer F
    Arch Cardiovasc Dis; 2010 Jan; 103(1):55-6. PubMed ID: 20142122
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation.
    Wechalekar AD; Offer M; Gillmore JD; Hawkins PN; Lachmann HJ
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):128-33. PubMed ID: 19079367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: an approach to diagnosis and management.
    Halwani O; Delgado DH
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare presentation of cardiac amyloid deposits isolated to intramural vessels.
    Clemmensen TS; Mølgaard H; Andersen NF; Baerentzen S; Soerensen J; Poulsen SH
    Echocardiography; 2016 Nov; 33(11):1777-1780. PubMed ID: 27600369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.
    Velazquez-Ceceña JL; Lubell DL; Nagajothi N; Al-Masri H; Siddiqui M; Khosla S
    Tex Heart Inst J; 2009; 36(1):50-4. PubMed ID: 19436787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation in a 68-year-old patient with senile systemic amyloidosis.
    Fuchs U; Zittermann A; Suhr O; Holmgren G; Tenderich G; Minami K; Koerfer R
    Am J Transplant; 2005 May; 5(5):1159-62. PubMed ID: 15816901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.